Quarterly report pursuant to Section 13 or 15(d)

NOTES PAYABLE (Details Narrative)

NOTES PAYABLE (Details Narrative) - USD ($)						1 Months Ended	3 Months Ended		6 Months Ended
NOTES PAYABLE (Details Narrative) - USD ($)	Aug. 01, 2024	Jul. 01, 2024	Mar. 06, 2024	Jun. 01, 2023	Jul. 28, 2020	Nov. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2024	Jun. 30, 2023	Dec. 31, 2023
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Unamortized Discount							$ 2,954,000		$ 2,954,000		$ 2,954,000
Interest Expense, Debt							600,000	$ 1,000,000	1,500,000	$ 1,900,000
Debt Instrument, Face Amount							10,820,000		10,820,000		16,304,000
Lenders [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Unamortized Discount							3,000,000		3,000,000
Share-Based Payment Arrangement, Tranche One [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument, Face Amount					$ 20,000,000
Insurance Policy [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Prepaid expenses							$ 100,000		$ 100,000		$ 300,000
Loan Agreement [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Notes payable						$ 400,000
Monthly principal and interest payments						$ 39,000
Monthly loan payments term						10-month period
Annual interest rate						8.15%
Loan Agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Annual interest rate							13.75%		13.75%
Debt conversion amount			$ 1,100,000	$ 900,000					$ 5,000,000
Debt conversion per share			$ 7.875	$ 4.5
Warrants to purchase shares of common stock, exercised			142,857	194,444	2,873
Warrant exercisable price per share					$ 208.8
Final payment					$ 1,600,000
Loan Agreement [Member] \| K2 HealthVentures LLC [Member] \| Share-Based Payment Arrangement, Tranche One [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Secured debt					$ 20,000,000
Loan Agreement [Member] \| Debt 1a [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion amount									3,000,000
Loan Agreement [Member] \| Debt 1a [Member] \| K2 HealthVentures LLC [Member] \| Minimum [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion amount									$ 900,000
Debt conversion per share							$ 4.5		$ 4.5
Loan Agreement [Member] \| Debt 1b [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion amount									$ 1,100,000
Debt conversion per share							7.875		$ 7.875
Loan Agreement [Member] \| Debt 2 [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt conversion amount									$ 3,000,000
Debt conversion per share							$ 282		$ 282
Amended loan agreement [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt Instrument Outstanding principal Amount							$ 10,800,000		$ 10,800,000
Debt Instrument, Face Amount							$ 12,400,000		12,400,000
Debt Instrument, Periodic Payment, Principal									$ 1,600,000
Amended loan agreement [Member] \| K2 HealthVentures LLC [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Debt description					The Company entered into an Amendment to the Loan and Security Agreement (the "Amended Loan and Security Agreement") on October 25, 2022. Interest payments are made monthly and accrue at a variable annual rate equal to the greater of (i) 8.5% and (ii) the rate of interest noted in The Wall Street Journal, Money Rates section, as the “Prime Rate” plus 5.25%, in each case, subject to a step-down of 25 basis points upon the funding of the second tranche.
Amended loan agreement [Member] \| Subsequent Event [Member]
SEC Schedule, 12-17, Insurance Companies, Reinsurance [Line Items]
Loan Maturity Final Amount	$ 11,800,000
Debt Instrument Outstanding principal Amount	10,100,000
Debt Instrument, Periodic Payment, Interest	$ 1,600,000
Debt Instrument, Issued, Principal		$ 700,000